아카디아 파마슈티컬스(ACADIA Pharmaceuticals Inc.)
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership3,464,689 shares
Latest Disclosed Value $ 77,137,406
Geode Capital Management, Llc reports 6.95% increase in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 3,464,689 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD) valued at $77,137,406 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 3,239,451 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of 6.95% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 3,464,689 225,238 6.95 77,137 -10.86 0.0026
2026-02-09 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 3,239,451 106,807 3.41 86,539 29.44 0.0053
2025-11-12 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 3,132,644 108,547 3.59 66,860 2.49 0.0043
2025-08-08 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 3,024,097 69,584 2.36 65,238 32.91 0.0046
2025-05-13 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,954,513 77,404 2.69 49,085 -7.05 0.0039
2025-02-12 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,877,109 1,569 0.05 52,807 19.38 0.0041
2024-11-12 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,875,540 30,826 1.08 44,234 -4.33 0.0036
2024-08-09 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,844,714 51,477 1.84 46,236 -10.49 0.0041
2024-05-13 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,793,237 101,085 3.75 51,654 -38.73 0.0048
2024-02-13 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,692,152 113,770 4.41 84,300 56.87 0.0088
2023-11-13 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,578,382 84,044 3.37 53,740 -10.04 0.0064
2023-08-11 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,494,338 104,071 4.35 59,739 32.80 0.0070
2023-05-15 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,390,267 90,768 3.95 44,985 124,855.56 0.0058
2023-02-13 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,299,499 78,348 3.53 37 -99.90 0.0051
2022-11-14 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,221,151 60,167 2.78 36,338 19.34 0.0055
2022-08-12 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,160,984 -41,441 -1.88 30,448 -42.92 0.0045
2022-05-13 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,202,425 38,273 1.77 53,342 5.60 0.0067
2022-02-11 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 2,164,152 143,000 7.08 50,511 50.46 0.0061
2021-11-12 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,021,152 -54,148 -2.61 33,571 -33.68 0.0045
2021-08-13 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 2,075,300 608,790 41.51 50,616 33.78 0.0070
2021-05-12 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,466,510 47,298 3.33 37,835 -50.13 0.0058
2021-02-12 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,419,212 88,896 6.68 75,871 38.26 0.0127
2020-11-13 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,330,316 -40,187 -2.93 54,875 -17.39 0.0108
2020-08-13 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,370,503 -357,567 -20.69 66,428 -9.02 0.0142
2020-05-14 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,728,070 107,011 6.60 73,010 5.28 0.0190
2020-02-20 2019-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 1,621,059 128,565 8.61 69,348 29.11 0.0145
2020-02-13 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,621,059 128,565 69,348 8,837.7945
2019-11-12 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,492,494 4,662 0.31 53,714 35.07 0.0125
2019-08-14 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,487,832 66,169 4.65 39,769 4.19 0.0096
2019-05-14 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,421,663 176,724 14.20 38,171 89.62 0.0099
2019-03-06 2018-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 1,244,939 177,701 16.65 20,130 -9.14 0.0062
2019-02-13 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,244,939 177,701 20,130
2018-11-13 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,067,238 62,605 6.23 22,155 44.43 0.0062
2018-08-14 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 1,004,633 99,084 10.94 15,340 -24.61 0.0047
2018-05-15 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 905,549 35,572 4.09 20,347 -22.32 0.0066
2018-02-13 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 869,977 24,847 2.94 26,195 -17.72 0.0089
2017-11-14 2017-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 845,130 54,720 6.92 31,836 44.43 0.0118
2017-08-14 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 790,410 29,578 3.89 22,043 -15.73 0.0087
2017-06-21 2017-03-31 13F/A-1 ACADIA PHARMACEUTICALS INC COM COM 004225108 760,832 63,421 9.09 26,157 30.05 0.0107
2017-05-12 2017-03-31 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 760,832 26,157
2017-02-14 2016-12-31 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 697,411 25,728 3.83 20,113 -5.86 0.0094
2016-11-10 2016-09-30 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 671,683 23,594 3.64 21,366 1.57 0.0108
2016-08-12 2016-06-30 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 648,089 -26,928 -3.99 21,036 11.46 0.0114
2016-05-13 2016-03-31 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 675,017 126,169 22.99 18,873 -3.54 0.0100
2016-02-12 2015-12-31 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 548,848 15,058 2.82 19,566 10.84 0.0112
2015-11-13 2015-09-30 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 533,790 14,477 2.79 17,652 -18.83 0.0107
2015-08-14 2015-06-30 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 519,313 15,427 3.06 21,748 32.45 0.0124
2015-05-14 2015-03-31 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 503,886 14,570 2.98 16,420 5.70 0.0094
2015-02-12 2014-12-31 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 489,316 11,258 2.35 15,535 31.25 0.0092
2014-11-14 2014-09-30 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 478,058 5,806 1.23 11,836 10.95 0.0077
2014-08-13 2014-06-30 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 472,252 29,337 6.62 10,668 -1.00 0.0069
2014-05-14 2014-03-31 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 442,915 59,289 15.45 10,776 12.41 0.0072
2014-02-14 2013-12-31 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 383,626 53,240 16.11 9,586 5.62 0.0066
2013-11-14 2013-09-30 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 330,386 27,754 9.17 9,076 65.23 0.0073
2013-08-14 2013-06-30 13F ACADIA PHARMACEUTICALS INC COM COM 004225108 302,632 302,632 5,493 0.0048
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.